Univest
Univest
  • Markets

3 Wind Turbines Maker, Hospitals Chain and Flow Control Equipment Maker Stocks With a Strong Future Roadmap: Suzlon Energy, Jupiter Life Line Hospitals and Jash Engineering

  • November 19, 2026
  • Posted by: Neeraj Pandey
  • Category: Best Stocks
No Comments
3 Wind Turbines Maker, Hospitals Chain and Flow Control Equipment Maker Stocks With a Strong Future Roadmap: Suzlon Energy, Jupiter Life Line Hospitals and Jash Engineering

Suzlon Energy, Jupiter Life Line Hospitals and Jash Engineering: ROE of 11.4% to 33.4% and FY22 to FY26 revenue CAGR of 19.3% to 26.4%. Prices as of 18 Nov 2026.

Quick Answer

The three wind turbine, heart hospital and valve stocks to watch are Suzlon Energy, Jupiter Life Line Hospitals and Jash Engineering. Their return on equity ranges from 11.4% to 33.4%, and their revenue compound annual growth from FY22 to FY26 ranges from 19.3% to 26.4%. Suzlon Energy leads on both return on equity at 33.4% and revenue growth at 26.4% a year. Prices are based on the 18 November 2026 close, and this article is educational, not investment advice.

Wind turbine, heart hospital and valve stocks offer a focused view of a sector where demand keeps widening. Suzlon Energy, Jupiter Life Line Hospitals and Jash Engineering cover a wind turbines maker, a hospitals chain and a flow control equipment maker.

This list covers three wind turbine, heart hospital and valve stocks with complete current figures: Suzlon Energy, Jupiter Life Line Hospitals and Jash Engineering. Every figure comes from the latest reported financials and the 18 November 2026 market close. Companies without complete current figures were left out.

Click Here – Get Free Investment Predictions

Table of Contents

Toggle
  • What Are Wind Turbine, Heart Hospital and Valve Stocks?
  • Wind Turbine, Heart Hospital and Valve Stocks at a Glance
  • Why Do Wind Turbine, Heart Hospital and Valve Stocks Have a Strong Roadmap in India?
  • Why Suzlon Energy Features Among These Wind Turbine, Heart Hospital and Valve Stocks
  • Why Jupiter Life Line Hospitals Features Among These Wind Turbine, Heart Hospital and Valve Stocks
  • Why Jash Engineering Features Among These Wind Turbine, Heart Hospital and Valve Stocks
  • Suzlon Energy vs Jupiter Life Line Hospitals vs Jash Engineering on Key Financials
  • Key Risks to Check Before Investing in Wind Turbine, Heart Hospital and Valve Stocks
  • Final Thoughts on Wind Turbine, Heart Hospital and Valve Stocks
    • What are wind turbine, heart hospital and valve stocks?
    • Which wind turbine, heart hospital and valve stocks are covered in this list?
    • Why do wind turbine, heart hospital and valve stocks have a strong future roadmap in India?
    • How has Suzlon Energy performed financially?
    • How has Jupiter Life Line Hospitals performed financially?
    • How has Jash Engineering performed financially?
    • What risks should investors check before buying wind turbine, heart hospital and valve stocks?
    • Is this list of wind turbine, heart hospital and valve stocks investment advice?

What Are Wind Turbine, Heart Hospital and Valve Stocks?

Wind turbine, heart hospital and valve stocks are listed companies that make wind turbines and provide wind farm services, run multi-speciality hospitals in western India, and make valves, gates and flow control equipment for water projects. Their earnings depend on wind power orders, patient numbers and water project spending.

Wind Turbine, Heart Hospital and Valve Stocks at a Glance

Company CMP (Rs) Market Cap (Rs Cr) P/E Industry P/E ROE (%) D/E
Suzlon Energy 36.13 55,008 17.5 43.9 33.4 0.06
Jupiter Life Line Hospitals 289.6 8,007 42.6 58.4 11.4 0.41
Jash Engineering 535.9 3,380 39.4 44.4 14.7 0.20

On valuation, all three trade at a P/E below their industry P/E, which means the market is pricing them at a lower multiple than their peer group. Readers comparing wind turbine, heart hospital and valve stocks should look at return on equity and debt together, since a high return earned with low debt is easier to sustain.

Why Do Wind Turbine, Heart Hospital and Valve Stocks Have a Strong Roadmap in India?

Wind turbine, heart hospital and valve stocks have a strong roadmap in India because growing clean energy capacity, wider access to quality hospital care and large water supply projects keep widening the market for these companies.

  • Wind turbines. Developers add wind power capacity.
  • Hospitals. Families seek advanced care.
  • Flow control. Water projects need gates and valves.

Why Suzlon Energy Features Among These Wind Turbine, Heart Hospital and Valve Stocks

Among the wind turbine, heart hospital and valve stocks on this list, Suzlon Energy is a wind turbine maker with manufacturing and service operations across India, supplying turbines for utility, independent power producer and corporate customers and servicing a large installed base.

In the June 2026 quarter, revenue grew 22.0% year on year to Rs 3,863 crore. Revenue rose from Rs 6,604 crore in FY22 to Rs 16,842 crore in FY26, a compound annual growth rate of 26.4%.

Net profit grew from Rs 2,072 crore in FY25 to Rs 3,163 crore in FY26, a rise of 52.7%. The company has a return on equity of 33.4%, a debt to equity ratio of 0.06 and a market capitalisation of Rs 55,008 crore. The stock trades at a P/E of 17.5, below the industry P/E of 43.9.

Roadmap: The company has a large order book and a strong share of the domestic wind market as the country adds renewable capacity. Its operations and maintenance business generates recurring income from the installed fleet.

What to watch: Check order book conversion to revenue and the pace of turbine deliveries each quarter.

Why Jupiter Life Line Hospitals Features Among These Wind Turbine, Heart Hospital and Valve Stocks

Among the clean power equipment, patient care and water control shares on this list, Jupiter Life Line Hospitals runs multi-speciality hospitals in Pune, Thane and Indore, with strong services in maternity, child care, critical care and advanced surgery.

The company has a return on equity of 11.4%, a debt to equity ratio of 0.41 and a market capitalisation of Rs 8,007 crore. The stock trades at a P/E of 42.6, below the industry P/E of 58.4.

Revenue rose from Rs 737 crore in FY22 to Rs 1,542 crore in FY26, a compound annual growth rate of 20.3%. Net profit grew from Rs 51.1 crore in FY22 to Rs 194 crore in FY26, which works out to a compound annual growth rate of 39.6%.

Roadmap: The company is adding beds and expanding to new locations while growing specialist services. Rising demand for quality private care in its cities supports occupancy.

What to watch: Follow bed additions, occupancy levels and revenue per occupied bed.

Why Jash Engineering Features Among These Wind Turbine, Heart Hospital and Valve Stocks

Among the three companies on this list, Jash Engineering makes flow control products such as sluice gates, valves, penstocks and screens for water and wastewater projects, and serves irrigation, power and industrial customers.

Revenue rose from Rs 374 crore in FY22 to Rs 757 crore in FY26, a compound annual growth rate of 19.3%. Net profit grew from Rs 32.2 crore in FY22 to Rs 75.5 crore in FY26, which works out to a compound annual growth rate of 23.8%.

In the June 2026 quarter, revenue grew 17.3% year on year to Rs 156 crore. The company has a return on equity of 14.7%, a debt to equity ratio of 0.20 and a market capitalisation of Rs 3,380 crore. The stock trades at a P/E of 39.4, below the industry P/E of 44.4.

Roadmap: Spending on water supply, sewage treatment and irrigation projects creates a steady stream of orders for flow control equipment. The company has widened its range through acquisitions and sells to customers in India and overseas.

What to watch: Track order inflow from water projects and the margin trend as new product lines scale.

Suzlon Energy vs Jupiter Life Line Hospitals vs Jash Engineering on Key Financials

The table below sets the three wind turbine, heart hospital and valve stocks side by side on revenue, profit and margin, using reported figures.

Company FY22 Revenue (Rs Cr) FY26 Revenue (Rs Cr) Revenue CAGR (FY22-FY26) FY26 Net Profit (Rs Cr) FY26 Net Margin
Suzlon Energy 6,604 16,842 26.4% 3,163 18.8%
Jupiter Life Line Hospitals 737 1,542 20.3% 194 12.6%
Jash Engineering 374 757 19.3% 75.5 10.0%

Suzlon Energy posts the highest return on equity in this group at 33.4%. Suzlon Energy combines the largest FY26 revenue at Rs 16,842 crore with the fastest revenue growth, a 26.4% compound annual rate. A useful habit with wind turbine, heart hospital and valve stocks is to check each new quarterly result against the capacity plans the company described earlier.

Key Risks to Check Before Investing in Wind Turbine, Heart Hospital and Valve Stocks

Every theme carries risks that deserve a check before any decision. For these wind turbine, heart hospital and valve stocks, the main points are: Long-term clean power equipment, patient care and water control shares holders usually track revenue growth, margins and cash flow side by side rather than relying on a single ratio.

  • Order timing. Project awards can shift between periods.
  • Capacity ramp up. New hospitals take time to fill beds and reach full returns.
  • Government spending. Public project funding can shift between periods.

Treat this list as a starting point for research and not as a recommendation. Read the latest results presentation, check the management commentary on order books or capacity plans, and compare each company with its peers before you decide anything.

Use the Univest Stock Screener to filter wind turbine, heart hospital and valve stocks by market capitalisation, P/E, ROE and growth, and build your own shortlist.

Final Thoughts on Wind Turbine, Heart Hospital and Valve Stocks

Wind turbine, heart hospital and valve stocks reward patient research into demand, execution and financial strength. Suzlon Energy, Jupiter Life Line Hospitals and Jash Engineering each have a clear plan to grow. Based on the 18 November 2026 close, Suzlon Energy trades at Rs 36.13, Jupiter Life Line Hospitals at Rs 289.6 and Jash Engineering at Rs 535.9.

Download the Univest iOS App or Univest Android App to track wind turbine, heart hospital and valve stocks, set price alerts and get research-backed stock ideas.

Disclaimer: Data and figures in this article are sourced from publicly available information. These may or may not be accurate. Please verify all data with the official NSE (nseindia.com) and BSE (bseindia.com) websites before making any investment decision. Investments in securities are subject to market risk. This content is for educational purposes only and is not investment advice by Univest (SEBI RA INH000013776).

What are wind turbine, heart hospital and valve stocks?

Ans. Wind turbine, heart hospital and valve stocks are listed companies that make wind turbines and provide wind farm services, run multi-speciality hospitals in western India, and make valves, gates and flow control equipment for water projects. Their earnings depend on wind power orders, patient numbers and water project spending. This list looks at three of them, Suzlon Energy, Jupiter Life Line Hospitals and Jash Engineering, using reported FY22 to FY26 financials and the 18 November 2026 closing prices.

Which wind turbine, heart hospital and valve stocks are covered in this list?

Ans. This list covers Suzlon Energy, Jupiter Life Line Hospitals and Jash Engineering. Based on the 18 November 2026 close, Suzlon Energy traded at Rs 36.13, Jupiter Life Line Hospitals at Rs 289.6 and Jash Engineering at Rs 535.9. Their return on equity ranges from 11.4% to 33.4%, and their revenue compound annual growth from FY22 to FY26 ranges from 19.3% to 26.4%.

Why do wind turbine, heart hospital and valve stocks have a strong future roadmap in India?

Ans. Wind turbine, heart hospital and valve stocks have a strong roadmap in India because growing clean energy capacity, wider access to quality hospital care and large water supply projects keep widening the market for these companies. The main drivers are as follows. Wind turbines. Developers add wind power capacity. Hospitals. Families seek advanced care. Flow control. Water projects need gates and valves. Together these factors give the companies on this list a visible path for growth over the coming years.

How has Suzlon Energy performed financially?

Ans. Revenue rose from Rs 6,604 crore in FY22 to Rs 16,842 crore in FY26, a compound annual growth rate of 26.4%. Net profit grew from Rs 2,072 crore in FY25 to Rs 3,163 crore in FY26, a rise of 52.7%. In the June 2026 quarter, revenue grew 22.0% year on year to Rs 3,863 crore. The company has a return on equity of 33.4%, a debt to equity ratio of 0.06 and a market capitalisation of Rs 55,008 crore. The stock trades at a P/E of 17.5, below the industry P/E of 43.9. Looking ahead, the company has a large order book and a strong share of the domestic wind market as the country adds renewable capacity. Its operations and maintenance business generates recurring income from the installed fleet.

How has Jupiter Life Line Hospitals performed financially?

Ans. Revenue rose from Rs 737 crore in FY22 to Rs 1,542 crore in FY26, a compound annual growth rate of 20.3%. Net profit grew from Rs 51.1 crore in FY22 to Rs 194 crore in FY26, which works out to a compound annual growth rate of 39.6%. The company has a return on equity of 11.4%, a debt to equity ratio of 0.41 and a market capitalisation of Rs 8,007 crore. The stock trades at a P/E of 42.6, below the industry P/E of 58.4. Looking ahead, the company is adding beds and expanding to new locations while growing specialist services. Rising demand for quality private care in its cities supports occupancy.

How has Jash Engineering performed financially?

Ans. Revenue rose from Rs 374 crore in FY22 to Rs 757 crore in FY26, a compound annual growth rate of 19.3%. Net profit grew from Rs 32.2 crore in FY22 to Rs 75.5 crore in FY26, which works out to a compound annual growth rate of 23.8%. In the June 2026 quarter, revenue grew 17.3% year on year to Rs 156 crore. The company has a return on equity of 14.7%, a debt to equity ratio of 0.20 and a market capitalisation of Rs 3,380 crore. The stock trades at a P/E of 39.4, below the industry P/E of 44.4. Looking ahead, spending on water supply, sewage treatment and irrigation projects creates a steady stream of orders for flow control equipment. The company has widened its range through acquisitions and sells to customers in India and overseas.

What risks should investors check before buying wind turbine, heart hospital and valve stocks?

Ans. Investors should check a few risks before buying wind turbine, heart hospital and valve stocks. Order timing. Project awards can shift between periods. Capacity ramp up. New hospitals take time to fill beds and reach full returns. Government spending. Public project funding can shift between periods. Reading the latest results presentation and comparing each company with its peers helps judge how these risks apply to each stock.

Is this list of wind turbine, heart hospital and valve stocks investment advice?

Ans. No. This article is educational and uses publicly available data as of the 18 November 2026 close. Please verify figures on NSE and BSE, read company filings and consult a SEBI registered adviser before investing. Univest is SEBI registered research analyst INH000013776.



Best Stocks clean power equipment heart hospital and valve stocks hospitals chain and flow control equipment stocks Jash Engineering Jupiter Life Line Hospitals patient care and water control shares Suzlon Energy wind energy wind turbine
Author: Neeraj Pandey
Neeraj Pandey is a Financial Content Writer at Univest, covering Indian equity markets with a specialisation in quarterly earnings previews and analyst consensus analysis. His published work tracks Q4 FY26 results across 10+ sectors — from IT heavyweights like Infosys and TCS to PSUs like Coal India and Balmer Lawrie, and mid-caps like Neuland Laboratories, MCX, and Whirlpool of India. His writing approach is data-first: every article anchors on NSE/BSE filings, analyst consensus estimates (revenue, PAT, EBITDA margins), 52-week price context, and YoY/QoQ comparisons — giving retail investors the same structured framework institutional desks use before an earnings event. He combines SEO-optimised structure with rigorous data sourcing, ensuring each preview ranks for investor search intent while meeting SEBI editorial standards. All articles are reviewed by Univest's in-house equity research team, led by Ankit Jaiswal, Senior Equity Research Analyst, to meet SEBI editorial standards.

Leave a Reply Cancel reply